Combined, expect a monthly investment of roughly $230 to $550 CAD, depending on your specific dosing protocol and supplier pricing
KFF survey shows that the following Medicaid prescription drug plan may cover at least one medication in the following states: Texas Virginia Wisconsin Pennsylvania South Carolina Rhode Island Michigan Minnesota Louisiana Kansas Mississippi New Hampshire Connecticut Delaware Hawaii California Medicare An estimated 91% of Medicare prescription drug plans cover Mounjaro for type 2 diabetes
There have also been documented local skin reactions when using GLP-1 RAs, particularly with the long-acting formulations
Patients have reported that as they lost weight while on semaglutide, their GERD symptoms became less frequent and less severe, suggesting a potential indirect benefit of the medication in managing acid reflux
Patients with sluggish response (less than 0.5% weekly weight loss despite caloric deficit) increase to 1.5ml weekly or add a second injection mid-week at 0.51ml
GLP-1 agonists are a class of medications originally developed to treat type 2 diabetes, but their benefits extend well beyond glycemic control